Glenmede Trust’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-201
Closed -$14K 2220
2020
Q3
$14K Sell
201
-33
-14% -$2.65K ﹤0.01% 1761
2020
Q2
$17K Buy
234
+85
+57% +$6.67K ﹤0.01% 1662
2020
Q1
$11K Hold
149
﹤0.01% 2400
2019
Q4
$11K Buy
149
+38
+34% +$2.8K ﹤0.01% 2400
2019
Q3
$7 Buy
+111
New +$7.45K ﹤0.01% 2519
2017
Q3
Sell
-4,874
Closed -$280K 2845
2017
Q2
$280K Hold
4,874
﹤0.01% 1104
2017
Q1
$280K Buy
+4,874
New +$291K ﹤0.01% 1104
2016
Q4
Sell
-6,286
Closed -$433K 2621
2016
Q3
$433K Buy
6,286
+14
+0.2% +$924 ﹤0.01% 970
2016
Q2
$349K Buy
+6,272
New +$378K ﹤0.01% 1024
2016
Q1
Sell
-3,778
Closed -$241K 2722
2015
Q4
$241K Sell
3,778
-1,838
-33% -$119K ﹤0.01% 1130
2015
Q3
$376K Buy
5,616
+1,070
+24% +$75.7K ﹤0.01% 1011
2015
Q2
$310K Buy
4,546
+1,860
+69% +$118K ﹤0.01% 1107
2015
Q1
$149K Hold
2,686
﹤0.01% 1348
2014
Q4
$137K Buy
+2,686
New +$132K ﹤0.01% 1428
2013
Q4
Sell
-4,612
Closed -$200K 2338
2013
Q3
$200K Buy
+4,612
New +$185K ﹤0.01% 1132

Other funds holding USNA

Glenmede Trust's USNA Position: Q4 2020 in Review

Glenmede Trust sold out of Usana Health Sciences (USNA) in Q4 2020, closing a stake of 201 shares — an estimated $14K sold.

Glenmede Trust first reported a position in USNA in Q3 2013 and held it in 15 quarters. The position peaked at $433K in Q3 2016. 191 funds tracked by Wall St. Rank hold USNA as of Q4 2020.

  • Glenmede Trust reported no remaining Usana Health Sciences position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 201 Usana Health Sciences shares in Q4 2020, an estimated $14K.
  • Glenmede Trust first reported a position in Usana Health Sciences in Q3 2013 and held it in 15 quarters.
  • Glenmede Trust's Usana Health Sciences position peaked at $433K in Q3 2016.
  • 191 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.